Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. | Chief Financial Officer | Common Stock | 2.42M | $4.99M | $2.06 | Jan 2, 2024 | Direct |
Cartesian Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 3.11M | $2.46M | $0.79 | Jan 2, 2024 | Direct |
Protara Therapeutics, Inc. | Chief Financial Officer | Common Stock | 20.7K | $39.5K | $1.91 | Jul 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Financial Officer |
SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 1 | -$988K | 4 | Nov 15, 2023 | Chief Financial Officer |
SELB | SELECTA BIOSCIENCES INC | Nov 28, 2022 | 1 | $0 | 4 | Nov 30, 2022 | Chief Financial Officer |
SELB | SELECTA BIOSCIENCES INC | Nov 28, 2022 | 0 | $0 | 3 | Nov 30, 2022 | Chief Financial Officer |
TARA | Protara Therapeutics, Inc. | Jul 15, 2022 | 1 | -$15.9K | 4 | Jul 19, 2022 | Chief Financial Officer |
TARA | Protara Therapeutics, Inc. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Chief Financial Officer |